$ARTC News

Last published 10mo ago

10mo agoARTC ARTCUArt Technology Acquisition Corp. Announces Pricing of $220,000,000 Initial Public OfferingGlobeNewswirePHILADELPHIA, PA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Art Technology Acquisition Corp. (NASDAQ:ARTCU) (the "Company") today announced the pricing of its initial public offering of 22,000,000 units at a price of $10.00
4y agoAPEN MDXG ARTCMIMEDX Announces Leadership TransitionGlobeNewswireK. Todd Newton Appointed as Interim Chief Executive Officer, Replacing Timothy R. Wright, Effective Immediately MARIETTA, Ga., Sept. 06, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company"), a transformational placen
5y agoAHCO ARTCAdaptHealth Corp. Announces Appointment of Greg Belinfanti as DirectorBusiness WireAdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Greg Belinfant
6y agoAXNX ARTCAxonics® Names Michael H. Carrel as Chairman of its Board of DirectorsBusiness WireIRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H. Carrel as chairman of the Axonics board of directors. Concurrent with this appointment, ...
12y agoARTCArthroCare Reports First Quarter 2014 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended March 31, 2014.
12y agoARTCArthroCare Reports Fourth Quarter and Full Year 2013 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended and year ended December 31, 2013.
12y agoARTCARTHROCARE SHAREHOLDERS NOTICE: Kendall Law Group Investigates Potentially Unfair Acquisition of ArthroCare Corp. by Smith & Nephew Plc.Business WireDALLAS--(BUSINESS WIRE)--Kendall Law Group, led by former federal judge Joe Kendall, is investigating the Board of Directors of ArthroCare Corp. (NYSE:ARTC) on behalf of shareholders in connection with the sale of the Company to Smith & Nephew Plc. for possible breaches of fiduciary duties and other violations of law. The national securities firm’s investigation seeks to determine whether ArthroCa ...
12y agoARTC SNNLaw Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ArthroCare Corporation StockholdersBusiness WireNEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (NASDAQ:ARTC) concerning the proposed acquisition of the Company by Smith & Nephew PLC (“Smith”) (NYSE:SNN). Under the terms of the definitive merger agreement, ArthroCare stockholders will receive $48.25 in cash for each share of ...
12y agoARTCFinkelstein Thompson LLP Investigates Potentially Unfair Buyout of ArthroCare CorporationBusiness WireWASHINGTON--(BUSINESS WIRE)--The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ArthroCare Corporation (Nasdaq: ARTC) (“ArthroCare” or “the Company”), concerning the Company’s proposed acquisition by Smith & Nephew plc. Under the terms of the proposal, ArthroCare shareholders will receive $48.25 in cash for each share of ArthroCare they own. At ...
12y agoARTCArthroCare Announces Entry into a Deferred Prosecution AgreementBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice (“DOJ”) entered into a Deferred Prosecution Agreement (“DPA”) filed today with the United States District Court in the Western District of Texas (the Court). The DPA will resolve the ongoing investigation by the DOJ regar ...
12y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
12y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
13y agoARTCArthroCare Reports Third Quarter 2013 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended September 30, 2013.
13y agoARTCArthroCare Announces Date for Third Quarter 2013 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its third quarter 2013 results on Tuesday, October 29, 2013.
13y agoHTGC OMTH ARTC CMLS+3Hercules Technology Growth Capital Announces Quarter-to-Date Portfolio Update for Q3 2013Business WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE: HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy and renewables technology industries, at all stages of development, today announced its quarter-to-d ...
13y agoARTCArthroCare Reports Second Quarter 2013 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the quarter ended June 30, 2013.
13y agoARTCArthroCare Announces Date for Second Quarter 2013 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2013 results on Monday, August 5, 2013.
13y agoHTGC ARTCHercules Technology Growth Capital Announces Second Quarter 2013 Financial Results and Raises Quarterly Cash Dividend to $0.28 per Share, up $0.01 From First Quarter 2013, an Increase of Approximately 3.7%Business WirePALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science and energy technology (aka cleantech) industries, at all stages of development, an ...
13y agoARTCArthroCare Announces Acquisition of ENTrigue Surgical, Inc.Business WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, today announced that it has completed the acquisition of ENTrigue Surgical, Inc., a privately held Delaware corporation (“ENTrigue”), in an all cash transaction.
13y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
13y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
13y agoARTCArthroCare Reports First Quarter 2013 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2013.
13y agoARTCArthroCare Announces Date for First Quarter 2013 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its first quarter 2013 results on Tuesday, May 7, 2013.
13y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
13y agoARTCArthroCare® Receives FDA Clearance for SpeedLock® HIP Knotless Fixation ImplantBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedLock HIP Knotless Fixation implant. SpeedLock HIP is a PEEK (polyether-etherketone) implant that is indicated for soft tissue fixation to bone in the ...
13y agoARTCArthroCare Reports Fourth Quarter and Full Year 2012 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2012.
13y agoARTCArthroCare to Host Conference Call on February 14, 2013Business WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corporation (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to release its fourth quarter and year end 2012 results on Thursday, February 14, 2013.
13y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
13y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
14y agoARTCArthroCare Reports Third Quarter 2012 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third quarter ended September 30, 2012.
14y agoARTCArthroCare Announces Date for Third Quarter 2012 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its third quarter 2012 results on Wednesday, October 31, 2012.
14y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
14y agoARTCArthroCare Reports Second Quarter 2012 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2012.
14y agoARTCArthroCare Announces Date for Second Quarter 2012 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2012 results on Wednesday, August 1, 2012.
14y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
14y agoARTCCompany Profile for ArthroCare CorporationBusiness Wire--(BUSINESS WIRE)--ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its internationally patented Coblation® technology. This technology precisely dissolves ...
14y agoARTCArthroCare Reports First Quarter 2012 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the first quarter ended March 31, 2012.
14y agoARTCArthroCare Announces Date for First Quarter 2012 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its first quarter 2012 results on Thursday, May 3, 2012.
14y agoARTCArthroCare Reports Fourth Quarter and Full Year 2011 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2011, as follows:
14y agoARTCArthroCare Announces Date for Fourth Quarter and Full Year 2011 Financial Results Press Release and Conference CallBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its fourth quarter and full year 2011 results on Thursday, February 16, 2011.
14y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
14y agoARTCArthroCare Announces Participation in Investor ConferenceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.
15y agoARTCArthroCare Reports Third Quarter 2011 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the third quarter ended September 30, 2011.
15y agoARTCArthroCare Announces Third Quarter 2011 Financial Results Press Release and Conference Call DatesBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its third quarter 2011 results on Wednesday, November 2, 2011.
15y agoARTCArthroCare® Receives FDA Clearance for SpeedLock® Knotless Fixation DeviceBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedLock® Knotless Fixation Device (SpeedLock). SpeedLock, a push-in implant made of PEEK (polyether-etherketone) polymer, provides surgeons with indepen ...
15y agoARTCArthroCare Reports Second Quarter 2011 Financial ResultsBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2011 as follows:
15y agoARTCArthroCare Announces Second Quarter 2011 Financial Results Press Release and Conference Call DatesBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to announce its second quarter 2011 results on Wednesday, August 3, 2011.
15y agoARTCArthroCare Receives FDA Clearance for SpeedFix™ Suture SystemBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedFix™ Suture System (SpeedFix™). SpeedFix, a push-in anchor made of PEEK (polyether-etherketone) polymer, is designed for the repair of tears of the l ...
15y agoARTCArthroCare Receives FDA Clearance for Spartan 6.5 Needled Suture ImplantBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare® Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan™ 6.5 Needled Anchor (Spartan). The Spartan device is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as ...
15y agoARTCArthroCare Announces Participation in Investor ConferencesBusiness WireAUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in two upcoming investor conferences, as detailed below.